Hyaluronidase Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hyaluronidase stocks.

Hyaluronidase Stocks Recent News

Date Stock Title
May 9 AMPH Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
May 9 AMPH Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
May 9 AMPH Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript
May 8 AMPH Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
May 8 AMPH Amphastar Pharmaceuticals Non-GAAP EPS of $1.04 beats by $0.25, revenue of $171.8M misses by $2.91M
May 8 AMPH Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
May 8 HALO Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
May 8 HALO Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates
May 8 HALO Q1 2024 Halozyme Therapeutics Inc Earnings Call
May 8 HALO Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
May 7 HALO Halozyme Therapeutics, Inc. (HALO) Q1 2024 Earnings Call Transcript
May 7 HALO Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 7 HALO Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
May 7 HALO Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
May 7 AMPH Amphastar Pharmaceuticals Q1 2024 Earnings Preview
May 7 HALO Halozyme Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 7 HALO Halozyme Therapeutics Non-GAAP EPS of $0.79 beats by $0.09, revenue of $195.88M misses by $3.77M
May 7 HALO HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
May 7 HALO Expert Ratings For Halozyme Therapeutics
May 6 HALO Halozyme Therapeutics Q1 2024 Earnings Preview
Hyaluronidase

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971 into three distinct groups, a scheme based on the enzyme reaction products. The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known as SPAM1 or PH-20); plus a pseudogene, HYAL6 (also known as HYALP1). The genes for HYAL1-3 are clustered in chromosome 3, while HYAL4-6 are clustered in chromosome 7. HYAL1 and HYAL2 are the major hyaluronidases in most tissues. GPI-anchored HYAL2 is responsible for cleaving high-molecular weight HA, which is mostly bound to the CD44 receptor. The resulting HA fragments of variable size are then further hydrolized by HYAL1 after being internalized into endo-lysosomes; this generates HA oligosaccharides.According to their enzymatic mechanism, hyaluronidases are hyaluronoglucosidases (EC 3.2.1.35), i.e. they cleave the (1->4)-linkages between N-acetylglucosamine and glucuronate. The term hyaluronidase may also refer to hyaluronoglucuronidases (EC 3.2.1.36), which cleave (1->3)-linkages. In addition, bacterial hyaluronate lyases (EC 4.2.2.1) may also be referred to as hyaluronidases, although this is uncommon.

Browse All Tags